Multiple courses of rituximab produce sustained clinical and radiographic efficacy and safety in patients with rheumatoid arthritis and an inadequate response to 1 or more tumor necrosis factor inhibitors: 5-year data from the REFLEX study.
J Rheumatol
; 39(12): 2238-46, 2012 Dec.
Article
em En
| MEDLINE
| ID: mdl-23027887
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Artrite Reumatoide
/
Fator de Necrose Tumoral alfa
/
Antirreumáticos
/
Anticorpos Monoclonais Murinos
/
Anticorpos Monoclonais
Idioma:
En
Ano de publicação:
2012
Tipo de documento:
Article